Clinical Trial on Yoga for people with HIV , Diabetes & Depresion

[Guest guest]

Yoga for Treating People at Risk for Diabetes or With Both HIV and

Depression

This study is currently recruiting patients.

Sponsored by: National Center for Complementary and Alternative

Medicine (NCCAM)

Information provided by: National Center for Complementary

and Alternative Medicine (NCCAM)

Purpose

The purpose of this study is to plan and develop an international

collaboration for research on the health effects of yoga. This study

will also determine the effects of yoga on people who are at an

increased risk for developing diabetes and people with both HIV and

depression.

Condition Treatment or Intervention Phase

HIV Infections

Diabetes

Depression Behavior: Yoga Phase I

MedlinePlus related topics: AIDS; Depression; Diabetes

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled,

Single Group Assignment, Efficacy Study

Official Title: Yoga, Health, and Meditation

Further Study Details:

Expected Total Enrollment: 50

Study start: July 2004

In recent years, western health practitioners have become

increasingly aware of the potential health benefits of yoga. This

study will comprise two substudies that will evaluate the effects of

yoga in two distinct populations.

Participants in the first study will be people who are at risk for

developing diabetes; participants in the second study will be people

with both HIV and depression. All participants will practice yoga 3

to 6 days per week for 3 months. Blood collection will be done and

weight and blood pressure measurements will be taken in study 1

participants; questionnaires will be used to measure depression and

stress in study 2 participants. All study participants will be

assessed at entry and at 3 and 6 months.

Eligibility

Ages Eligible for Study: 14 Years - 40 Years, Genders Eligible

for Study: Both

Criteria

Inclusion Criteria for Study 1 Participants:

• Meet certain laboratory requirements

Inclusion Criteria for Study 2 Participants:

• HIV infected

• Able to walk at least 50% of the time

Inclusion Criteria for All Participants:

• Written informed consent of parent/guardian, if applicable

Exclusion Criteria for Study 2 Participants:

• Require antiretroviral therapy

Location and Contact Information

Ragavendra Rao rao_raghav@...

India

Swami Vivekananda Yoga Anusandhana Samsthana (SVAYSA),

Bangalore, India; Recruiting

Ragavendra Rao, PhD, Sub-Investigator

Study chairs or principal investigators

Frederick M. Hecht, MD, Principal Investigator, UCSF Positive

Health Program

More Information

Study ID Numbers: 1-R21-AT001942-01

Record last reviewed: August 2004

Record first received: August 26, 2004

ClinicalTrials.gov Identifier: NCT00090506

Health Authority: United States: Federal Government

CinicalTrials.gov processed this record on 2005-01-19